You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 8,445,526


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,445,526
Title:Compositions and methods for treatment of glaucoma
Abstract: The invention provides .alpha.-2 adrenergic receptor agonist compositions and methods for treating glaucoma and other intraocular conditions. The preferred .alpha.-2 agonist used in the inventive compositions and methods is dexmedetomidine.
Inventor(s): Horn; Gerald (Deerfield, IL)
Assignee: Glaucoma & Nasal Therapies LLC (Dana Point, CA)
Application Number:13/585,563
Patent Claims:1. A pharmaceutical composition comprising i. dexmedetomidine as the only active ingredient at a concentration from between about 0.0125% to about 0.125% weight by volume; ii. a hypotonic salt or sterile water; iii. a poloxamer at a concentration of between 2% and 12% weight by volume; iv. a viscosity enhancer, wherein said pharmaceutical composition has a viscosity of between 25 and 500 cps, and wherein said pharmaceutical composition is effective for the treatment of glaucoma in a patient in need thereof.

2. The pharmaceutical composition of claim 1, wherein said dexmedetomidine is at a concentration from between about 0.035% to 0.10% weight by volume.

3. The pharmaceutical composition of claim 1, wherein said salt selected from the group consisting of sodium chloride, citrate, mesylate, hydrobromide/bromide, acetate, fumarate, sulfate/bisulfate, succinate, phosphate, maleate, nitrate, tartrate, benzoate, carbonate, and pamoate.

4. The pharmaceutical composition of claim 3, wherein said salt is sodium chloride.

5. The pharmaceutical composition of claim 1, wherein said viscosity enhancer is selected from carboxymethyl cellulose, methylcellulose, hydroxymethyl cellulose, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, polyethylene glycol, dextran, povidone, alginic acid, guar gum, acacia, veegum, gelatin, chitosan, carbopol, locust bean gum, acidic polycarbophil, dextran, pectin, povidone, polyvinylpyrridone, polyvinyl alcohol, and hyaluronic acid.

6. The pharmaceutical composition of claim 5, wherein said viscosity enhancer is carboxymethyl cellulose.

7. The composition of claim 6, wherein said carboxymethyl cellulose is of a high blend at a concentration of between 0.1% and 1.25%.

8. The pharmaceutical composition of claim 1, wherein said poloxamer is present at concentration range of 5% to 6% by weight.

9. The pharmaceutical composition of claim 1, wherein said poloxamer is selected from the group consisting of poloxamer 407, poloxamer 188, and combinations thereof.

10. The pharmaceutical composition of claim 1, further comprising a buffer.

11. The pharmaceutical composition of claim 10, wherein said buffer is selected from the group consisting of citrate buffer, borate buffer, maleate buffer, succinate buffer, phosphate buffer, acetate buffer, sorbate buffer and carbonate buffer.

12. The pharmaceutical composition of claim 11, wherein said buffer is at a concentration between 4 mM and 10 mM.

13. The pharmaceutical composition of claim 1, further comprising a mucoadhesive.

14. A pharmaceutical composition comprising: i. dexmedetomidine as the only active ingredient at a concentration from between 0.02% and about 0.12% weight by volume; ii. sodium chloride at a concentration of 0.25% to 0.50%; iii. a poloxamer at a concentration of between 3% and 12% weight by volume; iv. carboxymethyl cellulose (CMC), and wherein said pharmaceutical composition has a viscosity of between 50 and 200 cps, and wherein said pharmaceutical composition is effective for the treatment of glaucoma in a patient in need thereof.

15. A method of treating glaucoma in a patient in need thereof comprising administering to said patient the pharmaceutical composition of claim 1.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.